Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Transaction in Own Shares
-
EVS Broadcast Equipment reports update of share buyback program
-
Governor DeWine Announces Largest Singular Investment and Job-Creation Project in Defiance County History
-
Orange: Reduction of the Orange liquidity contract with Rothschild Martin Maurel
-
OMERS Earns $10.6 billion in Investment Income in 2024
-
Alberta Energy Regulator penalizes CST Canada Coal Ltd. for contraventions
-
The Honest Company CEO Carla Vernón Named to 2025 CNBC Changemakers: Women Transforming Business
-
Reporting on acquisition of treasury shares
-
Form 8.3 - Assura PLC
-
KLÉPIERRE UPGRADED to “A−” BY S&P
-
Societe Generale: Information regarding executed transactions within the framework of a share buyback program (outside the liquidity agreement)
-
ARAMIS GROUP - Declaration of transactions on own shares conducted from Feb 17 to Feb 21, 2025
-
Apex Defi Labs Inc. Announces Strategic Partnership with Regiment Securities to Expand Tokenized Securities Investment Opportunities
-
Compass Health announces the Marc Healing Center as name of state-of-the-art regional facility for intensive behavioral health services
-
Disclosure of transactions in on shares from February 19th to February 21st, 2025
-
Syensqo - Acquisition of own shares
-
ARGAN: 2024 UNIVERSAL REGISTRATION DOCUMENT MADE AVAILABLE
-
GTT strengthens its leadership team with the creation of a Group Transformation division and the appointment of a new Group Innovation VP
-
Melexis: update on the share buy-back program
-
RAPID + TCT 2025 Offers Largest Conference Ever
-
Ageas reports on the progress of share buy-back programme
-
IOGEAR Introduces Quantum Thunderbolt™ 5 Dock Pro: A Powerful Dock for Creative Professionals and Hybrid Workers
-
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 24 February 2025
-
Wrap Technologies Secures $5.8M in Private Placement of Securities
-
YourUpdateTV Speaks with Mathew Knowles and Ruth Tennen from 23andMe to Discuss Genetic Risk Factors for Cancer
-
DDB Miner Expands AI-Driven Cloud Mining Platform, Offering Stable Passive Income for Crypto Investors in 2025
-
Seven Major International Sports Federations Gather – The New Blueprint for Virtual & Simulated Sports is Mapped Out
-
Gentherm Reports Grant of Previously Announced CEO and CFO Inducement Awards Under Nasdaq Listing Rule
-
Shirofune to Present New LinkedIn Integration at eTail West 2025
-
Accellera Announces SystemC Summer of Code Program
-
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET
-
Veteran Software Leader Raphael Shure Named CEO of PowerPlan to Succeed Joe Gomes
-
Seven Major International Sports Federations Gather – The New Blueprint for Virtual & Simulated Sports is Mapped Out
-
Administrative Court upheld the administrative fine imposed on Verkkokauppa.com by the Data Protection Ombudsman's Sanctions Board
-
ENERQUALITY Announces New CEO
-
Kitron ASA - Notification of Primary insider transaction
-
SKYX Collaborating with U.S. Leading Prefabricated Home Manufacturer Cavco Homes
-
MAX Power Adds London-Based Natural Hydrogen Expert to Team
-
GXO Poland Named to 2025 Forbes Diamonds List
-
YourUpdateTV Speaks with Alanna Morris-Simon from Bayer to Discuss Key Risk Factors for Heart Disease and Resources That Can Help
-
Canada Metal Processing Group announces steps to respond to U.S. tariff threats on steel sector
-
Retail & Hospitality ISAC Appoints Three New Regional Vice Chairs to Support Global Initiatives
-
Retail & Hospitality ISAC Appoints Three New Regional Vice Chairs to Support Global Initiatives
-
NANO Nuclear Energy Announced as Two Star Partner of the Institute for Defense and Government Advancement’s Operational Energy Summit with CEO James Walker Scheduled to Present
-
SitePro Rentals Appoints Lon Jennings as New President
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
Pond Lehocky Adds Attorney James Garver to Workers’ Compensation and Social Security Disability Practices
-
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
-
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
-
Physicians Concerned AI Increases Prior Authorization Denials, Worsens Patient Harms & Waste
